高级搜索

宁夏地区2000—2014年肺癌构成比变化分析

高建梅, 张淑香, 吴文婷

高建梅, 张淑香, 吴文婷. 宁夏地区2000—2014年肺癌构成比变化分析[J]. 肿瘤防治研究, 2016, 43(11): 984-989. DOI: 10.3971/j.issn.1000-8578.2016.11.013
引用本文: 高建梅, 张淑香, 吴文婷. 宁夏地区2000—2014年肺癌构成比变化分析[J]. 肿瘤防治研究, 2016, 43(11): 984-989. DOI: 10.3971/j.issn.1000-8578.2016.11.013
GAO Jianmei, ZHANG Shuxiang, WU Wenting. Investigation of Dynamic Constituent Ratio Changes of Lung Cancer in Ningxia, 2000-2014[J]. Cancer Research on Prevention and Treatment, 2016, 43(11): 984-989. DOI: 10.3971/j.issn.1000-8578.2016.11.013
Citation: GAO Jianmei, ZHANG Shuxiang, WU Wenting. Investigation of Dynamic Constituent Ratio Changes of Lung Cancer in Ningxia, 2000-2014[J]. Cancer Research on Prevention and Treatment, 2016, 43(11): 984-989. DOI: 10.3971/j.issn.1000-8578.2016.11.013

宁夏地区2000—2014年肺癌构成比变化分析

基金项目: 

国家自然科学基金 81260356

详细信息
    作者简介:

    高建梅(1989-),女,硕士,主要从事呼吸内科学研究

    通讯作者:

    张淑香,E-mail: zsx95@126.com

  • 中图分类号: R734.2

Investigation of Dynamic Constituent Ratio Changes of Lung Cancer in Ningxia, 2000-2014

More Information
  • 摘要:
    目的 

    了解肺癌构成比的动态变化,及肺癌的部分流行病学特点。

    方法 

    收集宁夏医科大学总医院2000年1月至2014年12月经组织病理学或细胞学确诊为肺癌的住院患者,分析中央型肺癌与周围型肺癌构成比变化、不同病理类型构成比变化及肺癌在性别、发病年龄、吸烟等方面的变化趋势。

    结果 

    确诊的肺癌有3 608例,中央型肺癌(CLC)2 081例(57.68%),构成比呈下降趋势(P=0.000)。周围型肺癌(PLC)1 527例(42.32%),呈上升趋势(P=0.000)。其中鳞癌(SCC)构成比由2000—2004年的61.12%降至2010—2014年的38.90%(P=0.000);腺癌(AD)由36.82%升至60.10%(P=0.000)。CLC各病理类型构成比:SCC由63.57%降至42.44%(P=0.000)、AD由14.29%升至28.36%(P=0.000)、SCLC由17.38%升至26.38%(P=0.002)。PLC各病理类型构成比:SCC由25.32%降至16.89%(P=0.014)、AD由57.81%升至70.52%(P=0.001)。男性肺癌患者2 519例(69.82%),女性肺癌患者1 089例(30.18%)。男性肺癌发病人数构成比由75.80%降至67.18%(P=0.000),女性由24.20%升至32.82%(P=0.000);男性以SCC最常见,女性以AD最常见,男女患者SCC均呈下降趋势(P=0.000,P=0.000),AD均呈上升趋势(P=0.000,P=0.000)。SCC、SCLC平均发病年龄呈增大趋势(P=0.002,P=0.000),各病理类型均以≥60岁老年人群多见。AD吸烟人数构成比呈下降趋势(P=0.042)。

    结论 

    CLC构成比呈下降趋势,PLC呈上升趋势。CLC中SCC呈下降趋势,AD及SCLC呈上升趋势。PLC中SCC呈下降趋势,AD呈上升趋势,SCLC无明显变化。NSCLC中SCC呈下降趋势,AD呈上升趋势;SCLC变化无统计学意义。男性肺癌发病人数呈下降趋势,女性呈上升趋势。各病理类型肺癌发病年龄均无年轻化趋势。SCC和SCLC吸烟人数构成比无变化,AD吸烟人数呈下降趋势。

     

    Abstract:
    Objective 

    To analyze the constituent ratio changes of lung cancer and part of the epidemiological characteristics.

    Methods 

    We collected the clinical data of the patients who have been diagnosed as lung cancer by histopathology or cytology in the General Hospital of Ningxia Medical University from January,2000 to December,2014. And we analyzed the constituent ratio changes of central lung cancer(CLC) and peripheral lung cancer(PLC),changes of different pathological types and changes of gender,age and smoking status.

    Results 

    There were 3 608 cases of lung cancer diagnosed,including 2 081(57.68%) cases of CLCs and 1 527 (42.32%) cases of PLCs. The proportion of CLCs had decreased gradually(P=0.000) but PLCs had presented a rising tendency (P=0.000) . Including 1 328(46.13%)cases of squamous cell carcinomas(SCC) and 1 511(52.48%) cases of adenocarcinoma (AD). but SCC in NSCLC had decreased from 61.12% in 2000-2004 to 38.90% in 2010-2014(P=0.000) . AD had increased from 36.82% to 60.10% (P=0.000) . The proportion of 637(17.66%) cases of small cell lung cancer (SCLC) had no significant difference (P=0.194) . In CLC,there were 1 039 (49.93%) cases of SCC,483 (23.21%) cases of AD and 493(23.69%) cases of SCLC. In CLC,the proportions of SCC had decreased from 63.57% to 42.44% (P=0.000) ; AD had increased from 14.29% to 28.36% (P=0.000) ; SCLC had increased from 17.38% to 26.38% (P=0.002) . In PLC,the proportions of SCC had decreased from 25.32% to 16.89%(P=0.014) ; AD had increased from 57.81% to 70.52% (P=0.001) . There were 2 519(69.82%) male and 1 089(30.18%) female patients. The proportions of male patients had decreased from 75.80% to 67.18% (P=0.000) but the proportions of female patients had increased from 24.20% to 32.82% (P=0.000) . SCC was more common in men but AD was more common in women. In male and female patients,SCC had a downward trend (P=0.000,P=0.000) ,AD was on the rise(P=0.000,P=0.000) . The onset age of SCC and SCLC had showed a trend of increase (P=0.002,P=0.000) . SCC,AD and SCLC were more common in elderly people(≥60 years old). The constituent ratio of smoking in AD patients had a downward trend (P=0.042) .

    Conclusion 

    The proportion of CLC decreases gradually,while PLC presents a rising tendency; in CLC,SCC proportion decreases gradually but AD and SCLC increases obviously; in PLC,SCC proportion decreases gradually and AD increases obviously,while SCLC has no change. In NSCLC,SCC proportion has a downward trend,AD has a rising tendency,while SCLC has no significant difference. The number of male patients decreases but female patients increases gradually. There was no younger tendency in all types of lung cancer. The constituent ratio of smoking patients with SCC and SCLC has no changes while decreases in AD patients.

     

  • 图  1   CLC与PLC构成比变化

    Figure  1   Constituent ratio changes of CLC and PLC

    图  2   肺癌男女性别比构成变化

    Figure  2   Constituent ratio changes of lung cancer in male and female patients

    表  1   NSCLC与SCLC构成比

    Table  1   Constituent ratio changes of NSCLC and SCLC patients

    下载: 导出CSV

    表  2   肺癌不同病理类型构成比

    Table  2   Constituent ratio changes of different pathological types of lung cancer

    下载: 导出CSV

    表  3   肺癌不同病理类型构成比在性别上的变化

    Table  3   Constituent ratio changes of different pathological types in gender

    下载: 导出CSV

    表  4   不同病理类型肺癌的发病年龄和吸烟构成比

    Table  4   Onset ages and constituent ratio changes of smoking cases in different pathological types of lung cancer

    下载: 导出CSV

    表  5   不同年龄段不同病理类型肺癌构成比

    Table  5   Constituent ratio changes of different pathological types of lung cancer in age

    下载: 导出CSV
  • [1]

    Jemal A,Bray F,Center MM,et al. Global Cancer Statistics[J]. CA Cancer J Clin,2011,61(2): 69-90. doi: 10.3322/caac.v61:2

    [1] Jemal A, Bray F, Center MM, et al. Global Cancer Statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
    [2]

    Maher AR, Miake-Lye IM, Beroes JM, et al. Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review of Comparative Effectiveness and Cost-Effectiveness[M]. Washington : Department of Veterans Affairs (US),2012: 1-87.

    [2] Maher AR, Miake-Lye IM, Beroes JM, et al. Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review of Comparative Effectiveness and Cost-Effectiveness[M]. Washington : Department of Veterans Affairs (US), 2012: 1-87.
    [3] 陈万青,张思维,邹小农. 中国肺癌发病死亡的估计和流行趋势研究[J]. 中国肺癌杂志,2010,13(5): 488-93. http://www.cnki.com.cn/Article/CJFDTOTAL-FAIZ201005030.htm

    Chen WQ,Zhang SW,Zou XN. Estimation and Projection of Lung Cancer Incidence and Mortality in China[J]. Zhongguo Fei Ai Za Zhi,2010,13(5): 488-93. http://www.cnki.com.cn/Article/CJFDTOTAL-FAIZ201005030.htm

    [3] 陈万青, 张思维, 邹小农. 中国肺癌发病死亡的估计和流行趋势 研究[J]. 中国肺癌杂志, 2010, 13(5): 488-93. [Chen WQ, Zhang SW, Zou XN. Estimation and Projection of Lung Cancer Incidence and Mortality in China[J]. Zhongguo Fei Ai Za Zhi, 2010, 13(5): 488-93.]
    [4] Oken MM, Hocking WG, Kvale PA, et al. Screening by Chest Radiograph and Lung Cancer Mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Tria[J].JAMA, 2011, 306(17): 1865-73.
    [4]

    Oken MM,Hocking WG,Kvale PA,et al. Screening by Chest Radiograph and Lung Cancer Mortality: the Prostate, Lung,Colorectal,and Ovarian (PLCO) Randomized Tria[J].JAMA,2011,306(17): 1865-73. doi: 10.1001/jama.2011.1591

    [5] 葛均波,徐永健. 内科学[M]. 8版. 北京: 人民卫生出版社,2013:75-86.

    Ge JB,Xu YJ. Internal Medicine[M]. 8th ed. Beijing:People’s Medical Publishing House,2013: 75-86.

    [5] 葛均波, 徐永健. 内科学[M]. 8版. 北京: 人民卫生出版社, 2013. 75-86. [Ge JB, Xu YJ. Internal Medicine[M]. 8th ed. Beijing: People’s Medical Publishing House, 2013. 75-86.]
    [6] 陈云萍,李建成,张江灵,等. 中晚期非小细胞肺癌调强放疗临床疗效[J]. 临床荟萃,2015,30(1): 48-50,51. http://www.cnki.com.cn/Article/CJFDTOTAL-LCFC201501013.htm

    Chen YP,Li JC,Zhang JL,et al. Clinical Effect of Intensity Modulated Radiation Therapy for Treatment of Local Medium and Advanced Non-Small Cell Lung Cancer[J]. Lin Chuang Hui Cui,2015,30(1): 48-50,51. http://www.cnki.com.cn/Article/CJFDTOTAL-LCFC201501013.htm

    [6] 陈云萍, 李建成, 张江灵, 等. 中晚期非小细胞肺癌调强放疗临 床疗效[J]. 临床荟萃, 2015, 30(1): 48-50, 51. [Chen YP, Li JC, Zhang JL, et al. Clinical Effect of Intensity Modulated Radiation Therapy for Treatment of Local Medium and Advanced Non- Small Cell Lung Cancer[J]. Lin Chuang Hui Cui, 2015, 30(1): 48-50, 51.]
    [7] 顾其华, 胡成平, 宋敏, 等. 中央型肺癌病理类型构成比变迁分 析[J]. 肿瘤防治研究, 2011, 38(3): 333-6. [Gu QH, Hu CP, Song M, et al. Analyzing the Investigation of Dynamic constituent ratio Changes of Various pathological types in Central Lung Cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 2011, 38(3): 333-6.]
    [7] 顾其华,胡成平,宋敏,等. 中央型肺癌病理类型构成比变迁分析[J]. 肿瘤防治研究,2011,38(3): 333-6. http://www.zlfzyj.com/CN/abstract/abstract3431.shtml

    Gu QH,Hu CP,Song M,et al. Analyzing the Investigation of Dynamic constituent ratio Changes of Various pathological types in Central Lung Cancer[J]. Zhong Liu Fang Zhi Yan Jiu,2011,38(3): 333-6. http://www.zlfzyj.com/CN/abstract/abstract3431.shtml

    [8]

    Langer CJ,Besse B,Gualberto A,et al. The evolving role of histology in themanagement of advanced non-small-cell lung cancer[J]. J Clin Oncol,2010,28(36): 5311-20. doi: 10.1200/JCO.2010.28.8126

    [8] Langer CJ, Besse B, Gualberto A, et al. The evolving role of histology in themanagement of advanced non-small-cell lung cancer[J]. J Clin Oncol, 2010, 28(36): 5311-20.
    [9]

    Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer,2010,127(12): 2893-917. doi: 10.1002/ijc.v127:12

    [9] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-917.
    [10] 于楠, 张喆, 郭佑民. 女性肺癌研究的新进展[J]. 现代肿瘤医 学, 2012, 20(7): 1500-3. [Yu N, Zhang Z, Guo YM. The New Progress in The Study of Female Lung Cancer[J]. Xian Dai Zhong Liu Yi Xue, 2012, 20(7): 1500-3.]
    [10] 于楠,张喆,郭佑民. 女性肺癌研究的新进展[J]. 现代肿瘤医学,2012,20(7): 1500-3. http://www.cnki.com.cn/Article/CJFDTOTAL-SXZL201207066.htm

    Yu N, Zhang Z, Guo YM. The New Progress in The Study of Female Lung Cancer[J]. Xian Dai Zhong Liu Yi Xue,2012,20(7): 1500-3. http://www.cnki.com.cn/Article/CJFDTOTAL-SXZL201207066.htm

    [11] Kligerman S, White C. Epidemiology of Lung Cancer in Women: Risk Factors, Survival, and Screening [J]. AJR Am J Roentgenol, 2011, 196(2): 287-95.
    [11]

    Kligerman S,White C. Epidemiology of Lung Cancer in Women: Risk Factors,Survival,and Screening [J]. AJR Am J Roentgenol,2011,196(2): 287-95. doi: 10.2214/AJR.10.5412

    [12] Jemal A, Siegel R, Xu J, et al. Cancer Statistics,2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300.
    [12]

    Jemal A,Siegel R,Xu J,et al. Cancer Statistics,2010[J]. CA Cancer J Clin,2010,60(5): 277-300. doi: 10.3322/caac.20073

    [13] 姚晓军, 张洪伟, 蒲强, 等. 2000年与2010年四川大学华西医院 收治肺癌患者的临床流行病学特征及病理类型分布特点[J]. 四川大学学报(医学版), 2014, 45(2): 309-15. [Yao XJ, Zhang HW, Pu Q. Clinical Epidemiology and Histologic Characteristics of Patients with Lung Cancer in West China Hospital of Sichuan University[J]. Sichuan Da Xue Xue Bao(Yi Xue Bann). 2014, 45(2): 309-15.]
    [13] 姚晓军,张洪伟,蒲强,等. 2000年与2010年四川大学华西医院收治肺癌患者的临床流行病学特征及病理类型分布特点[J]. 四川大学学报(医学版),2014,45(2): 309-15. http://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201402030.htm

    Yao XJ,Zhang HW,Pu Q. Clinical Epidemiology and Histologic Characteristics of Patients with Lung Cancer in West China Hospital of Sichuan University[J]. Sichuan Da Xue Xue Bao(Yi Xue Bann). 2014,45(2): 309-15. http://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201402030.htm

    [14]

    Akgün KM, Crothers K, Pisani M. Epidemiology and management of common pulmonary diseases in older persons[J]. J Gerontol A Biol Sci Med Sci,2012,67(3): 276-91. http://cn.bing.com/academic/profile?id=2164841138&encoded=0&v=paper_preview&mkt=zh-cn

    [14] Akgün KM, Crothers K, Pisani M. Epidemiology and management of common pulmonary diseases in older persons[J]. J Gerontol A Biol Sci Med Sci, 2012, 67(3): 276-91.
    [15] 刘良燕,杜庆峰,孙泽峰. 1249例肺癌临床分析[J]. 海南医学,2014,25(23): 3524-5. http://www.cnki.com.cn/Article/CJFDTOTAL-HAIN201423031.htm

    Liu LY,Du QF,Sun ZF. Clinical Analysis of 1249 Cases of Lung Cancer[J]. Hainan Yi Xue,2014,25(23): 3524-5. http://www.cnki.com.cn/Article/CJFDTOTAL-HAIN201423031.htm

    [15] 刘良燕, 杜庆峰, 孙泽峰. 1249例肺癌临床分析[J]. 海南医学, 2014, 25(23): 3524-5. [Liu LY, Du QF, Sun ZF. Clinical Analysis of 1249 Cases of Lung Cancer[J]. Hainan Yi Xue, 2014, 25(23): 3524-5.]
    [16] Wang JB, Jiang Y, Wei WQ, et al. Estimation of cancer incidence and mortality attributable to smoking in china[J]. Cancer Causes Control, 2010, 21(6): 959-65.
    [16]

    Wang JB,Jiang Y,Wei WQ,et al. Estimation of cancer incidence and mortality attributable to smoking in china[J]. Cancer Causes Control,2010,21(6): 959-65. doi: 10.1007/s10552-010-9523-8

    [17]

    Reck M,Heigener DF,Mok T,et al,Management of non-small cell lungcancer: recent developments[J]. Lancet,2013,382(9893): 709-19. doi: 10.1016/S0140-6736(13)61502-0

    [17] Reck M, Heigener DF, Mok T, et al, Management of non-small cell lungcancer: recent developments[J]. Lancet, 2013, 382(9893): 709-19.
图(2)  /  表(5)
计量
  • 文章访问数:  1593
  • HTML全文浏览量:  397
  • PDF下载量:  275
  • 被引次数: 0
出版历程
  • 收稿日期:  2016-01-21
  • 修回日期:  2016-03-23
  • 网络出版日期:  2024-02-04
  • 刊出日期:  2016-10-31

目录

    /

    返回文章
    返回
    x 关闭 永久关闭